Ryu et al. used MALDI-MSI to analyze the distribution of alectinib (an ALK inhibitor) in NB1 (with ALK amplification) and SK-N-FI (ALK wild-type) NB xenograft tissues [173]. Here, ALK is linked to neuroblastoma.